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Abstract
Introduction To prospectively examine the relation of total,
vigorous and non-vigorous physical activity to postmenopausal
breast cancer risk.
Methods We studied 32,269 women enrolled in the Breast
Cancer Detection Demonstration Project Follow-up Study.
Usual physical activity (including household, occupational and
leisure activities) throughout the previous year was assessed at
baseline using a self-administered questionnaire.
Postmenopausal breast cancer cases were identified through
self-reports, death certificates and linkage to state cancer
registries. A Cox proportional hazards regression was used to
estimate the relative risk and 95% confidence intervals of
postmenopausal breast cancer associated with physical activity.
Results During 269,792 person-years of follow-up from 1987
to 1998, 1506 new incident cases of postmenopausal breast
cancer were ascertained. After adjusting for potential risk
factors of breast cancer, a weak inverse association between
total physical activity and postmenopausal breast cancer was
suggested (relative risk comparing extreme quintiles = 0.87;
95% confidence interval = 0.74 to 1.02; p for trend = 0.21).
That relation was almost entirely contributed by vigorous activity
(relative risk comparing extreme categories = 0.87; 95%
confidence interval = 0.74 to 1.02; p for trend = 0.08). The
inverse association with vigorous activity was limited to women
who were lean (ie, body mass index <25.0 kg/m2: relative risk =
0.68; 95% confidence interval = 0.54 to 0.85). In contrast, no
association with vigorous activity was noted among women who
were overweight or obese (ie, body mass index ≥ 25.0 kg/m2:
relative risk = 1.18; 95% confidence interval = 0.93 to 1.49; p
for interaction = 0.008). Non-vigorous activity showed no
relation to breast cancer (relative risk comparing extreme
quintiles = 1.02; 95% confidence interval = 0.87 to 1.19; p for
trend = 0.86). The physical activity and breast cancer relation
was not specific to a certain hormone receptor subtype.
Conclusions In this cohort of postmenopausal women, breast
cancer risk reduction appeared to be limited to vigorous forms
of activity; it was apparent among normal weight women but not
overweight women, and the relation did not vary by hormone
receptor status. Our findings suggest that physical activity acts
through underlying biological mechanisms that are independent
of body weight control.
Introduction
Breast cancer is the most common malignancy among women
in the US. It was estimated that 178,000 new breast cancer
cases would occur in 2007 and that 40,000 women would die
from the disease [1]. Two recent systematic reviews [2,3] con-
cluded that data from epidemiological studies strongly sug-
gest an inverse relation of physical activity to breast cancer,
but that results are limited by an inadequate characterisationPage 1 of 11
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activity. The reviews called for further research aimed at eluci-
dating what aspects of physical activity contribute most
towards decreasing risk. We therefore examined total, vigor-
ous and non-vigorous activity of all types (household, occupa-
tional and recreational activities) in relation to breast cancer
risk in a large prospective cohort of women enrolled in the




The BCDDP was a mammography demonstration program
jointly sponsored by the National Cancer Institute and the
American Cancer Society [4]. The program enrolled 283,222
participants who underwent breast examinations between
1973 and 1980 in one of 29 screening centres located in 27
cities across the US. In 1979, the National Cancer Institute
established the BCDDP Follow-up Study of 64,182 women
enrolled in the original BCDDP screening study. The BCDDP
Follow-up Study cohort included: all women diagnosed with
breast cancer during BCDDP screening (n = 4275); all
women with benign breast disease confirmed by biopsy but
with no malignant disease (n = 25,114); all women who were
recommended by the BCDDP for surgical consultation but for
whom no procedure was performed (n = 9628); and a random
sample of BCDDP participants who had no surgery or recom-
mendation for surgical consultation during screening (n =
25,165).
Since its inception in 1979, the BCDDP Follow-up Study has
proceeded in several phases. Phase 1 from 1979 to 1986
involved a telephone interview at baseline and up to six annual
telephone follow-up interviews through 1986. Phases 2, 3 and
4 each used individual, self-administered questionnaires that
were mailed between 1987 and 1989, 1993 and 1995, and
1995 and 1998, respectively, to all cohort members who were
presumed alive at the end of the previous phase. The question-
naires were designed to gather basic demographic informa-
tion, to update exposures to various potential risk factors for
chronic disease and to ascertain newly diagnosed cancer.
Non-respondents to mailed questionnaires were interviewed
by telephone, if possible. The BCDDP Follow-up Study was
approved by the Institutional Review Board of the National
Cancer Institute, and informed consent was obtained from all
participants.
Population for analysis
The phase 2 questionnaire, which first requested information
on physical activity and formed the baseline of the current
report, was returned by 81% of the original 64,182 partici-
pants of the BCDDP Follow-up Study. Of these 51,696
women who were aged 40 to 93 years at baseline, we
excluded from the current analysis those with a breast cancer
diagnosis before phase 2 (n = 5152), women with other pre-
vious cancers other than non-melanoma skin cancer (n =
2877), those who were premenopausal throughout the dura-
tion of follow-up (n = 102), those with missing or inadequate
information on physical activity (n = 10,314), and those who
provided inadequate data on calorie intake (n = 658), body
weight (n = 300) or height during any phase (n = 26). The pri-
mary analyses in the current study are based on the remaining
32,269 women, who were followed from 1987 to 1998. Of
these, 91% completed the phase 3 questionnaire, 85% com-
pleted the phase 4 questionnaire and 94% completed either
the phase 3 or phase 4 questionnaires.
Most participants in the population for analysis were Cauca-
sian (89%), with small percentages being African American
(3%), Asian (5%), Hispanic (2%) or of other or missing race/
ethnicity (1%). The majority of participants (85%) were post-
menopausal at baseline.
Assessment of physical activity
Usual physical activity during the previous year was assessed
by asking subjects to estimate the number of hours per typical
weekday and weekend day they spent engaging in moderate
and vigorous physical activities. The questionnaire encom-
passed an extensive list of examples of moderate and vigorous
activities that covered household, occupational, and recrea-
tional or sporting activities. Examples of moderate activity
(referred to as non-vigorous activity) included light housework,
vacuuming, washing clothes, painting, home repairs, lawn
mowing, general gardening, raking, light sports or exercise,
walking, hiking, light jogging, recreational tennis, bowling, golf
and bicycling on a level ground. Examples of vigorous activity
included heavy housework such as scrubbing floors or wash-
ing windows, heavy yard-work, digging in the garden, chop-
ping wood, strenuous sports or exercise, running, fast jogging,
competitive tennis, aerobics, bicycling on hills and fast danc-
ing. Our questionnaire also queried about the time spent
sleeping and engaging in sedentary behaviours (examples
included sitting, office work, driving a car, occupations that
involved standing or walking, watching television, and read-
ing). We did not consider the information regarding sleeping
and sedentary behaviours in our current analysis of physical
activity.
The reported hours per day spent in non-vigorous and vigor-
ous activities were converted to weekly average hours using
the following formula: [(weekday hours × 5) + (weekend hours
× 2)]/7. A weekly physical activity score was calculated for
non-vigorous and vigorous activity by multiplying the time
spent at each category of activity by its energy expenditure
requirements, expressed as metabolic equivalent tasks
(METs) [5]. One MET is defined as the energy expended sit-
ting quietly, which is equivalent to an oxygen uptake of 3.5 ml/
kg/minute for an adult weighing 70 kg [6]. Because categories
included numerous individual activities, they were assigned an
average MET value: four METs for non-vigorous activity and sixPage 2 of 11
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(total physical activity) was calculated by summing up the
weekly expenditures from non-vigorous and vigorous activities.
The methods used to calculate the physical activity variables
build on previous work in this cohort [7].
Our method of assessing physical activity has not undergone
a direct comparison with physical activity logs or other valida-
tion tools. However, our physical activity assessment is similar
to that employed in the Framingham Heart Study, which dem-
onstrated a correlation between questionnaire-based and indi-
rect calorimetry-based physical activity of 0.43 [8]. In addition,
our physical activity measure includes selected components
of the College Alumnus Physical Activity Questionnaire [9], an
assessment tool that is positively correlated with maximum
oxygen uptake, percentage body fat, high-density lipoprotein
levels and body mass index (BMI) [10,11].
Identification of breast cancer cases
We identified new incident breast cancer cases through
pathology reports, linkage to state cancer registries, the
National Death Index (from 31 December 1997) and from self-
reports. Pathology reports were sought for all self-reported
cancers. In addition, about 80% of the cohort was linked to
state cancer registries using the state of last known residence
at the time of the phase 4 questionnaire mailing. Using these
methods, we ascertained a total of 1506 postmenopausal
breast cancer cases, of which 260 (17%) were classified as
in situ cancers. Of the breast cancer cases, 1147 (76%) were
identified based on information collected from pathology
reports, 198 (13%) were ascertained using information pro-
vided by state cancer registries and 161 (11%) were self-
reported breast cancers with no pathology report or data from
a state registry. We had an insufficient number of premeno-
pausal breast cancer cases to provide stable individual risk
estimates; thus, we limited all analyses to postmenopausal
breast cancer. Sensitivity analyses were conducted excluding
the 260 cases with in situ breast cancer and excluding the
161 cases who self-reported breast cancer, but for whom we
lacked confirmation. Results were similar to the overall result
and are not reported separately.
We also evaluated breast cancer risk according to hormone
receptor status, information of which was obtained from can-
cer registries serving our cohort. The threshold for a positive
hormone receptor status was 10 fmol or more of receptor per
milligram of total protein. Because a proportion of our cases
was identified through self-reporting and because certain can-
cer registries do not routinely collect data regarding hormone
receptor status, information on hormone receptor status was
unavailable for 639 breast cancer cases (42%). Thus, analy-
ses regarding hormone receptor status disregarded those
cases. Women for whom hormone receptor data was available
did not differ by age, education level or physical activity from
women for whom such information was not available (data not
shown).
Statistical analysis
Person-time of follow-up for each participant began at the
return date of the phase 2 questionnaire and it ended at the
date of breast cancer diagnosis, death from any cause or date
of return of the phase 4 questionnaire. The exit date of a par-
ticipant who was lost to follow-up was assigned as the date of
last contact during 1995 and 1998 or, if the individual could
not be contacted, the date of their last completed question-
naire plus the mean time between completion of successfully
completed questionnaires derived from the cohort as a whole.
We used Cox proportional hazards regression [12] to esti-
mate the relative risk (RR) of breast cancer using person-years
of follow-up as a metric time and adjusting for age at baseline
(continuous), family history of breast cancer (any first- or sec-
ond-degree relative; yes, no or unknown), history of benign
breast disease (any benign breast disease before study base-
line, including during the screening stages; yes or no),
BCDDP screening subgroup (women who had undergone a
breast biopsy as part of the BCDDP screening but lacked evi-
dence of malignant disease, women who were recommended
for surgical consultation as part of the BCDDP but for whom
the procedure was not performed, and women who repre-
sented a random sample of BCDDP participants who had no
surgery or recommendation for surgical consultation during
BCDDP screening), height (continuous), age at menarche (11
and younger, 12, 13 or 14 and older years of age), age at men-
opause, including women whose periods stopped as a result
of hysterectomy (age at which menstrual period stopped for at
least three continuous months; younger than 47 or 47 years of
age or older), age at first live birth (continuous), history of oral
contraceptive use (yes or no), menopausal hormone therapy
(ever or never), education attainment (less than or equal to
high school or greater than high school), cigarette smoking
(ever or never), and intakes of energy-adjusted dietary fat (con-
tinuous) and alcohol (continuous). Terms for total and non-vig-
orous physical activity were divided into quintiles. Vigorous
activity was grouped such that women who reported a daily
average of zero hours were placed into one category and
those who reported nonzero values were divided into quartiles.
Information on education and height was collected on entry
into the original screening program. Data regarding age at
menarche, age at first live birth and oral contraceptive use was
collected during phase 1 of the study. Current body weight,
diet, smoking habits, information on menopause including hys-
terectomy status, and menopausal hormone therapy use was
assessed using the phase 2 questionnaire.
We conducted secondary analyses that were additionally
adjusted for mammography subsequent to the screening
phase (yes or no), history of bone fracture after age 45 yearsPage 3 of 11
(page number not for citation purposes)
Breast Cancer Research    Vol 10 No 5    Leitzmann et al.(yes or no) and history of osteoporosis (yes or no) to assess
the potential for confounding by those variables. Because BMI
potentially represents a causal pathway linking increased
physical activity to decreased breast cancer risk, we did not
include BMI in our primary analyses. However, additional mod-
els contained BMI to assess the impact of physical activity on
breast cancer independent of its effect on body weight. In
addition, the relation of physical activity to breast cancer risk
was evaluated within strata of BMI. We used a BMI cut-off
point of 25.0 kg/m2 to distinguish lean or normal weight
women from overweight or obese women.
Statistical interaction of BMI and other known or suspected
breast cancer risk factors was examined by entering the cross-
product term for physical activity and a given variable with the
main effects terms for each in the appropriate multivariate
model, the coefficients for which were evaluated using a Wald
test. Tests for linear trend were conducted by entering a single
ordinal variable corresponding to the median of the physical
activity category into the model. All hypothesis tests were two-
sided and associations were considered to be statistically sig-
nificant if p < 0.05. All analyses were conducted using SAS
release 9.1.3 (SAS Institute, Cary, NC).
Results
In our study population, the range of total physical activity var-
ied about 2.5-fold between the means of extreme quintiles.
Women reported spending an average of 1.2 hours a day in
vigorous activity and 5.9 hours a day in non-vigorous activity.
We first examined physical activity in relation to potential con-
founding factors for breast cancer (Table 1). Women who
Table 1
Baseline characteristics according to quintiles of total physical activity in 32,269 women in the Breast Cancer Detection 
Demonstration Project (BCDDP)*
Characteristic Quintile of total physical activity
1 2 3 4 5
Participants (n) 6453 6454 6441 6472 6449
Age (years) 61.7 61.1 61.3 60.8 61.0
MET-hours/week (range) † 105 to 244 245 to 297 298 to 339 340 to 394 395 to 721
Vigorous physical activity (hours/week) 0.9 3.6 5.4 10.3 22.7
Non-vigorous physical activity (hours/week) 14.8 32.4 46.5 54.5 59.7
Body mass index (kg/m2) 25.4 25.0 24.9 24.7 24.6
Height (inches) 64.3 64.2 64.2 64.2 64.1
Ever smoked cigarettes (%) 46.9 44.6 43.4 42.1 40.7
Education (% more than high school) 55.0 50.0 46.8 46.1 42.0
Age at first birth (years) ‡ 24.0 23.9 23.8 23.9 23.5
Parity (number of births) ‡ 2.8 2.8 2.9 2.9 3.0
Age at menarche (years) 12.7 12.7 12.8 12.8 12.9
Age at menopause (years) 50.4 50.3 50.2 50.4 50.3
History of oral contraceptive use (%) 33.8 33.2 33.4 32.8 31.1
Current menopausal hormone therapy (%) 55.3 54.7 55.8 55.7 54.1
Family history of breast cancer (%) ¶ 34.0 35.1 34.1 34.4 33.6
History of benign breast disease (%) § 55.5 56.0 55.4 55.6 55.2
Total energy intake (kcal/day) 1252 1256 1266 1271 1277
Dietary fat intake (g/day) || 46.9 46.5 46.3 46.0 45.9
Alcohol intake (g/day) 4.5 4.4 4.1 4.0 3.6
* All values (except age and range of MET-hours/week) are directly standardised to the age distribution of the cohort at study baseline.
† MET = metabolic equivalent task. The MET value is the caloric need per kilogram of body weight per hour of activity divided by the caloric need 
per kilogram of body weight per hour at rest.
‡ Among parous women only.
¶Family history of breast cancer includes first- and second-degree relatives with a history breast cancer.
§The BCDDP Follow-up Study includes a disproportionate number of women with benign breast disease due to the design of the original 
BCDDP.
||Adjusted for total energy intake.Page 4 of 11
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have never smoked, to have a lower level of education and to
have greater parity than physically less active women. Differ-
ences between physically active and physically inactive
women with respect to age at first birth, age at menopause,
history of oral contraceptive use and menopausal hormone
therapy tended to be minimal.
During 269,792 person-years of follow-up, we documented
1506 cases of postmenopausal breast cancer. In age-
adjusted analyses, total physical activity was inversely related
to risk of postmenopausal breast cancer (Table 2). The most
active women had an age-adjusted RR of 0.81 (95% confi-
dence interval (CI) = 0.69 to 0.95; p = 0.03) as compared with
the least active women. The relative risk was slightly attenu-
ated and became statistically non-significant after additional
adjustment for potential confounding variables (RR = 0.86;
95% CI = 0.73 to 1.01; p = 0.15). Additional adjustment for
BMI did not change the relationship (RR = 0.87; 95% CI =
0.74 to 1.02; p = 0.21). Results were virtually identical in sec-
ondary models that were also adjusted for mammography sub-
sequent to the screening phase, history of bone fracture after
age 45 years, and history of osteoporosis (0.87; 95% CI =
0.74 to 1.02; p = 0.22).
The apparent inverse association between total physical activ-
ity and postmenopausal breast cancer was virtually entirely
contributed by vigorous physical activity (Table 3). After
adjusting for multiple confounding factors including non-vigor-
ous activity and BMI, women in the highest category of vigor-
ous activity had an RR of 0.87 (95% CI = 0.74 to 1.02; p =
0.08) compared with women with no vigorous activity. When
we examined deciles of vigorous physical activity, the RR in
the top category (n = 70) was 0.79 (95% CI = 0.61 to 1.01)
(data not tabulated). In contrast, non-vigorous activity showed
no association with risk for postmenopausal breast cancer
(multivariate RR comparing extreme quintiles = 1.02; 95% CI
= 0.87 to 1.19; p = 0.86).
We investigated the relation of physical activity to postmeno-
pausal breast cancer within strata of BMI (Table 4). Among
normal weight and lean women (BMI < 25.0 kg/m2), the multi-
variate RRs comparing extreme categories of total and vigor-
ous activity were 0.76 (95% CI = 0.61 to 0.94; p = 0.03) and
0.68 (95% CI = 0.54 to 0.85; p = 0.002), respectively. The
test for interaction between vigorous activity and BMI was sta-
tistically significant (p = 0.008). In contrast, the relations of
total and non-vigorous activity to breast cancer were not sta-
tistically significantly modified by BMI (p = 0.19 and 0.47,
respectively).
We subdivided breast cancer cases according to hormone
receptor status and found no evidence that the relation
between physical activity and breast cancer was specific to a
certain hormone receptor subtype, neither before (data not
shown) or after adjustment for BMI (Table 5).
The relations of total, vigorous and non-vigorous activity with
postmenopausal breast cancer risk were not further modified
by other potential breast cancer risk factors, including age,
breast cancer screening history, family history of breast can-
cer, history of benign breast disease, age at menarche, age at
first birth, parity, menopausal hormone use, age at menopause,
Table 2
Relative risk of postmenopausal breast cancer in relation to total physical activity among US women in the Breast Cancer Detection 
Demonstration Project (BCDDP; 1987 to 1998)*
Variable Quintile of total physical activity p
1 2 3 4 5
Physical activity
MET-hours/week (range) 105 to 244 245 to 297 298 to 339 340 to 394 395 to 721
Cases 320 300 308 312 266
Person-years 52,858 53,967 54,019 54,487 54,461
Age-adjusted RR (95% CI) 1.0 0.92 (0.79 to 1.08) 0.94 (0.81 to 1.10) 0.95 (0.82 to 1.12) 0.81 (0.69 to 0.95) 0.03
Multivariate RR † (95% CI) 1.0 0.92 (0.79 to 1.08) 0.97 (0.83 to 1.14) 0.98 (0.84 to 1.15) 0.86 (0.73 to 1.01) 0.15
Multivariate RR ‡ (95% CI) 1.0 0.93 (0.80 to 1.09) 0.98 (0.84 to 1.14) 1.00 (0.85 to 1.16) 0.87 (0.74 to 1.02) 0.21
* CI = confidence interval; MET = metabolic equivalent task; RR = relative risk.
† The multivariate model included the following: age at baseline (continuous), family history of breast cancer (any first- or second-degree relative; 
yes, no or unknown), history of benign breast disease (any benign breast disease prior to study baseline, including during the screening stages; 
yes or, no), breast cancer screening history (women who had undergone a breast biopsy as part of the BCDDP screening but lacked evidence of 
malignant disease, women who were recommended for surgical consultation as part of the BCDDP but for whom the procedure was not 
performed, or women who represented a random sample of BCDDP participants who had no surgery or recommendation for surgical consultation 
during BCDDP screening), height (continuous), age at menarche (≤ 11, 12, 13 or 14+ years of age), age at menopause (age at which menstrual 
period stopped for at least three continuous months; <47 or 47+ years of age), age at first live birth (continuous), history of oral contraceptive use 
(yes or no), menopausal hormone therapy (ever or never), education attainment (less than or equal to high school, or greater than high school), 
cigarette smoking (ever or never), and intakes of energy-adjusted dietary fat (continuous) and alcohol (continuous).
‡ Also controlled for body mass index (continuous).Page 5 of 11
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tary intakes of alcohol and total dietary fat (p > 0.05).
Discussion
We found that a higher amount of vigorous physical activity
was associated with a small, statistically non-significant
decrease in postmenopausal breast cancer risk in our cohort
as a whole. However, when we evaluated the relation of vigor-
ous activity to breast cancer among women who were of nor-
mal weight, the association became markedly stronger, with
risk among women reporting the highest amount of vigorous
activity decreasing by about 30% compared with women with
no vigorous activity. In contrast, no association between vigor-
ous activity and breast cancer was noted among women who
were overweight or obese. In addition, we observed no asso-
ciation between non-vigorous activity and breast cancer, nei-
ther in the cohort as a whole or after stratification by BMI. We
also found no heterogeneity of the physical activity and breast
cancer association according to hormone receptor status.
As published in a recent meta-analysis of the available litera-
ture [2], most previous studies that examined physical activity
in relation to postmenopausal breast cancer reported risk
reductions of 20% to 80% for the highest compared with the
lowest physical activity levels. Some [13-15] but not all previ-
ous investigations [16-21] noted a significant inverse relation
with vigorous activity but detected a weaker or no association
with non-vigorous activity. That vigorous activity may afford
greater apparent protection from breast cancer development
than non-vigorous activity is supported by findings that greater
intensity of physical activity or level of physical training is
related to more pronounced perturbations of sex hormone lev-
els and menstrual function [22]. However, data from ran-
domised trials among postmenopausal women demonstrate
that circulating levels of androstenedione and oestrone, impor-
tant modulators of breast cancer risk, are lowest among
women assigned to engaging in the most amount of overall
activity [23-25], suggesting that the amount of activity is more
relevant than the intensity of activity, at least for reducing oes-
trogen levels.
Table 3
Relative risk of postmenopausal breast cancer in relation to vigorous and non-vigorous physical activity among US women in the 
Breast Cancer Detection Demonstration Project (BCDDP: 1987 to 1998)*
Variable Category of vigorous or non-vigorous physical activity p
1 2 3 4 5
Vigorous physical activity
MET-hours/week 0 0.1 to 48.9 49.0 to 70.0 70.1 to 126.0 126.1 to 588.0
Cases 614 236 234 218 204
Person-years 101,276 40,772 44,949 41,072 41,772
Age-adjusted RR (95% CI) 1.0 1.00 (0.86 to 1.17) 0.89 (0.76 to 1.03) 0.90 (0.77 to 1.06) 0.82 (0.70 to 0.96) 0.008
Multivariate RR † §(95% CI) 1.0 0.98 (0.84 to 1.14) 0.88 (0.76 to 1.03) 0.91 (0.78 to 1.07) 0.86 (0.73 to 1.01) 0.06
Multivariate RR ‡ §(95% CI) 1.0 0.98 (0.85 to 1.15) 0.89 (0.76 to 1.04) 0.92 (0.79 to 1.08) 0.87 (0.74 to 1.02) 0.08
Non-vigorous physical activity
MET hours per week 0 to 84.0 84.1 to 140.0 140.1 to 188.0 188.1 to 229.0 229.1 to 504.0
Cases 317 314 283 287 305
Person-years 53,660 56,791 52,224 53,001 54,116
Age-adjusted RR (95% CI) 1.0 0.94 (0.80 to 1.09) 0.91 (0.78 to 1.07) 0.91 (0.77 to 1.06) 0.95 (0.81 to 1.11) 0.48
Multivariate RR † || (95% CI) 1.0 0.99 (0.84 to 1.16) 0.98 (0.83 to 1.16) 0.97 (0.82 to 1.14) 1.01 (0.86 to 1.18) 0.96
Multivariate RR ‡ || (95% CI) 1.0 0.99 (0.84 to 1.16) 0.99 (0.84 to 1.16) 0.97 (0.82 to 1.14) 1.02 (0.87 to 1.19) 0.86
* CI = confidence interval; MET = metabolic equivalent task; RR = relative risk.
† The multivariate model included the following: age at baseline (continuous), family history of breast cancer (any first- or second-degree relative; 
yes, no or unknown), history of benign breast disease (any benign breast disease prior to study baseline, including during the screening stages; 
yes or no), breast cancer screening history (women who had undergone a breast biopsy as part of the BCDDP screening but lacked evidence of 
malignant disease, women who were recommended for surgical consultation as part of the BCDDP but for whom the procedure was not 
performed, or women who represented a random sample of BCDDP participants who had no surgery or recommendation for surgical consultation 
during BCDDP screening), height (continuous), age at menarche (≤ 11, 12, 13 or 14+ years of age), age at menopause (age at which menstrual 
period stopped for at least three continuous months; <47 or 47+ years of age), age at first live birth (continuous), history of oral contraceptive use 
(yes or no), menopausal hormone therapy (ever or never), education attainment (less than or equal to high school or greater than high school), 
cigarette smoking (ever or never), and intakes of energy-adjusted dietary fat (continuous) and alcohol (continuous).
‡ Also controlled for body mass index (continuous).
§Also controlled for non-vigorous physical activity (quintiles).
||Also controlled for vigorous activity (5 categories).Page 6 of 11
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was modified by BMI, with an inverse physical activity associ-
ation limited to lean or normal weight women. This is consist-
ent with numerous previous studies [16,17,26-35] observing
an apparent protective effect of physical activity on breast can-
cer risk that was more evident among lean women than over-
weight women. However, data regarding this issue are
equivocal, with some reports noting a more pronounced
inverse physical activity and breast cancer relation among
overweight women compared with lean women [36-38], and
other investigations finding no heterogeneity of the associa-
tion between physical activity and breast cancer according to
adiposity level [14,19,39-46].
That increased physical activity was related to a more pro-
nounced reduction in risk for breast cancer among lean
women compared with overweight women and the observa-
tion that the influence of physical activity was almost unaf-
fected by adjustment for BMI suggests an underlying
biological mechanism that is independent of body weight con-
trol. Possible mechanisms through which physical activity may
protect against breast cancer that are independent of BMI
include reduced exposure to growth factors, enhanced
immune function and decreased chronic inflammation, varia-
bles that are related both to greater physical activity and to
lower breast cancer risk [47].
A non-causal explanation for a stronger inverse relation of vig-
orous activity among lean women compared with overweight
women is that heavier women may not exercise as intensely as
lean women. Moreover, non-vigorous activities performed by
overweight women, such as light housework, general garden-
ing and light sports, may be misreported as vigorous activities
among overweight individuals.
Table 4
Relative risk of postmenopausal breast cancer in relation to total, vigorous and non-vigorous physical activity in subgroups defined 
by body mass index among US women in the Breast Cancer Detection Demonstration Project (BCDDP; 1987 to 1998)*








< 25.0 kg/m2 876 1.0 0.88 (0.71 to 
1.08)
0.92 (0.75 to 
1.12)
0.91 (0.74 to 
1.11)
0.76 (0.61 to 
0.94)
0.03
≥ 25.0 kg/m2 630 1.0 1.01 (0.79 to 
1.29)
1.07 (0.84 to 
1.37)
1.12 (0.88 to 
1.43)






< 25.0 kg/m2 876 1.0 0.87 (0.72 to 
1.07)
0.81 (0.67 to 
0.99)
0.90 (0.73 to 
1.10)
0.68 (0.54 to 
0.85)
0.002
≥ 25.0 kg/m2 630 1.0 1.15 (0.91 to 
1.46)
1.00 (0.79 to 
1.27)
0.93 (0.72 to 
1.21)






< 25.0 kg/m2 876 1.0 0.97 (0.79 to 
1.20)
1.05 (0.85 to 
1.31)
0.97 (0.78 to 
1.20)
0.98 (0.79 to 
1.21)
0.85
≥ 25.0 kg/m2 630 1.0 1.01 (0.79 to 
1.28)
0.90 (0.69 to 
1.16)
0.98 (0.77 to 
1.27)
1.09 (0.85 to 
1.39)
0.59 0.47
CI = confidence interval; RR = relative risk. The multivariate model included the following: age at baseline (continuous), family history of breast 
cancer (any first- or second-degree relative; yes, no or unknown), history of benign breast disease (any benign breast disease prior to study 
baseline, including during the screening stages; yes or no), breast cancer screening history (women who had undergone a breast biopsy as part of 
the BCDDP screening but lacked evidence of malignant disease, women who were recommended for surgical consultation as part of the BCDDP 
but for whom the procedure was not performed, or women who represented a random sample of BCDDP participants who had no surgery or 
recommendation for surgical consultation during BCDDP screening), height (continuous), age at menarche (≤ 11, 12, 13 or 14+ years of age), 
age at menopause (age at which menstrual period stopped for at least three continuous months; <47 or 47+ years of age), age at first live birth 
(continuous), history of oral contraceptive use (yes or no), menopausal hormone therapy (ever or never), education attainment (less than or equal 
to high school or greater than high school), cigarette smoking (ever or never), and intakes of energy-adjusted dietary fat (continuous) and alcohol 
(continuous). Within each stratum, the group with lowest vigorous physical activity served as the reference group.
† Body mass index is the weight in kilograms divided by height in metres squared.Page 7 of 11
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ity to breast cancer varied according to hormone receptor sub-
type, although information on hormone receptor status was
available for only a portion of the study subjects. This finding is
in line with several previous studies on this topic
[14,26,48,49]. Some investigations did find heterogeneity of
the physical activity relation by breast cancer hormone recep-
tor status. For example, in the California Teachers Study [15]
increased levels of both strenuous and moderate recreational
activity were related to decreased risks of oestrogen receptor
(ER)-negative, but not ER-positive breast cancers. In the Iowa
Women's Study [50] enhanced physical activity level was
associated with decreased risks of ER-positive/progesterone
receptor (PR)-positive, ER-positive/PR-negative and ER-nega-
tive/PR-negative breast cancers. However, the only breast
cancers for which a statistically significant inverse relation
remained after adjustment for BMI were ER-positive/PR-nega-
tive types. A case-control study found a suggestive inverse
relation of current recreational activity with ER-negative breast
cancers and an apparent increased risk with ER-positive
breast cancers [51]. However, the directionality of those asso-
ciations was reversed when considering adolescent recrea-
tional activity [51]. Taken together, available data concerning
the relation of physical activity to breast cancer according to
hormone receptor subtype are currently not sufficiently con-
sistent to draw firm conclusions.
Despite reasonable consistency of our findings with those
from the existing literature [2], a direct comparison of activity
levels among women in our study with those from previous
investigations is difficult because of substantial variation in the
design of physical activity questionnaires across available
breast cancer studies. Our questionnaire format may have
been associated with some degree of over-reporting of activity
as suggested by circumstantial data showing that self-admin-
istered activity questions can lead to inflated estimates of the
reported time spent engaging in physical activity as compared
with interviewer-administered assessments [52]. However, the
main possible correlates of activity over-reporting, including
Table 5
Relative risk of oestrogen receptor positive (ER+) breast cancer and oestrogen receptor negative (ER-) breast cancer in relation to 
vigorous physical activity among US women in the Breast Cancer Detection Demonstration Project (BCDDP; 1987 to 1998)*
Variable No. of Cases Category of vigorous physical activity p
1 2 3 4 5
ER/PR receptor status
ER+ 706 1.0 0.94 0.93 0.93 0.91 (0.72 to 1.15) 0.42
PR+ 588 1.0 1.13 0.97 1.03 0.93 (0.72 to 1.22) 0.54
ER+/PR+ 555 1.0 1.08 0.97 1.02 0.93 (0.71 to 1.23) 0.61
ER+/PR- 115 1.0 2.40 0.89 0.97 0.49 (0.10 to 2.32) 0.22
ER- 161 1.0 1.36 0.79 1.02 0.74 (0.44 to 1.27) 0.22
PR- 248 1.0 0.77 0.74 0.80 0.77 (0.52 to 1.15) 0.23
ER-/PR+ 29 1.0 0.55 0.60 0.56 0.81 (0.46 to 1.41) 0.43
ER-/PR- 126 1.0 1.02 0.80 1.06 0.76 (0.42 to 1.35) 0.43
Combination of ER receptor status and BMI
ER+, BMI < 25.0 kg/m2 417 1.0 0.79 0.87 0.95 0.75 (0.54 to 1.03) 0.15
ER+, BMI ≥ 25.0 kg/m2 289 1.0 1.20 1.01 0.86 1.19 (0.83 to 1.69) 0.60
Combination of ER/PR receptor status and BMI
ER+/PR+, BMI < 25.0 kg/m2 327 1.0 0.94 0.93 1.09 0.81 (0.56 to 1.17) 0.43
ER+/PR+, BMI ≥ 25.0 kg/m2 228 1.0 1.29 1.02 0.89 1.14 (0.76 to 1.71) 0.81
BMI = body mass index; CI = confidence interval; ER = oestrogen receptor; PR = progesterone receptor; RR = relative risk. The multivariate 
model included the following: age at baseline (continuous), family history of breast cancer (any first or second degree relative; yes, no or 
unknown), history of benign breast disease (any benign breast disease prior to study baseline, including during the screening stages; yes or no), 
breast cancer screening history (women who had undergone a breast biopsy as part of the BCDDP screening but lacked evidence of malignant 
disease, women who were recommended for surgical consultation as part of the BCDDP but for whom the procedure was not performed, or 
women who represented a random sample of BCDDP participants who had no surgery or recommendation for surgical consultation during 
BCDDP screening), height (continuous), age at menarche (≤ 11, 12, 13 or 14+ years of age), age at menopause (age at which menstrual period 
stopped for at least three continuous months; <47 or 47+ years of age), age at first live birth (continuous), history of oral contraceptive use (yes or 
no), menopausal hormone therapy (ever or never), education attainment (less than or equal to high school or greater than high school), cigarette 
smoking (ever or never), and intakes of energy-adjusted dietary fat (continuous) and alcohol (continuous). Within each stratum, the group with 
lowest vigorous physical activity served as the reference group.Page 8 of 11
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Available online http://breast-cancer-research.com/content/10/5/R92age and body size, were accounted for in our multivariate sta-
tistical analyses.
Our physical activity tool included an assessment of physical
activity intensity, which appeared to be sufficiently compre-
hensive to distinguish between vigorous and non-vigorous
forms of activity. Nonetheless, we cannot rule out the possibil-
ity of misclassification of non-vigorous and vigorous types of
activities in our study, which would tend to attenuate relative
risk estimates due to random error in capturing and quantifying
the most relevant intensity of physical activity. Although our
questionnaire was aimed at assessing all types of physical
activity, it lacked the level of refinement necessary to evaluate
specific individual activities, such as walking.
Women who were more physically active in our cohort tended
to have a lower education level than those who were less
active. Thus, we cannot entirely rule out the possibility that the
inverse association between vigorous activity and breast can-
cer observed in our study was partly explained by lower soci-
oeconomic status related both to increased activity levels and
to decreased risk of breast cancer. On the other hand, lower
socioeconomic status among physically active women indi-
cates that a combination of household and occupational activ-
ities represented a quantitatively greater contribution to total
physical activity among women in our cohort than in other
studies in which physical activity assessments were limited to
recreational or sports activities, which tend to track positively
with elements of a healthy lifestyle and also bear the potential
for confounding [51].
Our analysis was based on a single, baseline assessment of
physical activity, which may not have precisely represented
long-term activity habits. Data on physical activity throughout
the life course would have been important in examining early-
age or long-term physical activity patterns in relation to subse-
quent breast cancer risk [49]. Our findings suggest that phys-
ical activity in mid to late adulthood is aetiologically relevant for
influencing breast cancer risk.
We did not encompass possible alterations in activity levels
during follow-up. Conceivably, our single point-in-time meas-
ure of physical activity misclassified women with respect to
their habitual activity level during the study. In particular,
women in our cohort who had recently undergone surgical
consultation or therapy for benign breast disease may have
subsequently modified their physical activity habits. Because
our physical activity questionnaire was designed to assess
recent exposure to physical activity, any impact of breast can-
cer screening on activity levels during the subsequent period
of follow-up would have diminished the ability of our instrument
to reflect true long-term physical activity levels. However,
because our physical activity assessment preceded the diag-
nosis of breast cancer, potential misclassification of physical
activity would have tended to be non-differential with respect
to disease status, which would have resulted in an attenuation
of the true association. In addition, findings from other pro-
spective cohorts [53] indicate that physical activity levels tend
to track well over time, which helps explain why investigations
employing a single baseline measure have uncovered relevant
associations between physical activity and breast cancer
using that strategy.
We also were not able to encompass changes in potential
confounding variables or effect modifiers during follow-up.
Large changes in levels of variables such as BMI or menopau-
sal hormone therapy use could have influenced our findings.
Notable strengths of our study include its large sample size,
prospective design, high follow-up rate, and availability of rel-
evant known or suspected breast cancer risk factors. These
features enabled us to minimise major bias and confounding.
Consistent with the majority of previous investigations of phys-
ical activity and breast cancer [2], few variables confounded
our findings.
An important limitation of our study is our reliance on self-
reported physical activity, a method that is prone to both sys-
tematic and random errors. A further potential limitation is that
our cohort comprised predominantly Caucasian women who
volunteered to participate in a long-term follow-up study. Thus,
our findings may not be strictly relevant to all women. In addi-
tion, women who had undergone a previous breast biopsy
were over-sampled in our study, potentially further decreasing
the general nature of our results. However, the relation of phys-
ical activity to breast cancer was not modified by breast can-
cer screening history in our study, suggesting broad
applicability of our results.
Conclusions
In conclusion, our results support the hypothesis of an inverse
association between physical activity and postmenopausal
breast cancer. Risk reduction appeared to be limited to vigor-
ous forms of activity. Our data also suggest that the potential
protective effect of vigorous activity on postmenopausal
breast cancer risk is most apparent among lean or normal
weight rather than overweight women. Possible reasons for
such heterogeneity include both causal and non-causal mech-
anisms. The physical activity and breast cancer relation did not
vary according to hormone receptor status. Thus, that particu-
lar aspect of our study revealed little additional mechanistic
insight into breast cancer aetiology. Future studies designed
to evaluate in detail the relations of individual components of
physical activity, including specific vigorous and non-vigorous
activities throughout the life course in relation to risk of breast
cancer overall and by hormone receptor phenotype will allow
further insights into possible biological mechanisms of breast
carcinogenesis.Page 9 of 11
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